28471040|t|Farnesylthiosalicylic acid -loaded lipid-polyethylene glycol-polymer hybrid nanoparticles for treatment of glioblastoma
28471040|a|We aimed to develop lipid-polyethylene glycol (PEG)-polymer hybrid nanoparticles, which have high affinity to tumour tissue with active ingredient, a new generation antineoplastic drug, farnesylthiosalicylic acid (FTA) for treatment of glioblastoma. Farnesylthiosalicylic acid -loaded poly(lactic-co-glycolic acid)-1,2 distearoyl-glycerol-3-phospho-ethanolamine-N [methoxy (PEG)-2000] ammonium salt (PLGA-DSPE-PEG) with or without 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) hybrid nanoparticles has been prepared and evaluated for in-vitro characterization. Cytotoxicity of FTA-loaded nanoparticles along with its efficacy on rat glioma-2 (RG2) cells was also evaluated both in vitro (in comparison with non-malignant cell line, L929) and in vivo. Scanning electron microscopy studies showed that all formulations prepared had smooth surface and spherical in shape. FTA and FTA-loaded nanoparticles have cytotoxic activity against RG2 glioma cell lines in cell culture studies, which further increases with addition of DOTAP. Magnetic resonance imaging and histopathologic evaluation on RG2 tumour cells in rat glioma model (49 female Wistar rats, 250-300 g) comparing intravenous and intratumoral injections of the drug have been performed and FTA-loaded nanoparticles reduced tumour size significantly in in-vivo studies, with higher efficiency of intratumoral administration than intravenous route. Farnesylthiosalicylic acid -loaded PLGA-DSPE-PEG-DOTAP hybrid nanoparticles are proven to be effective against glioblastoma in both in-vitro and in-vivo experiments.
28471040	0	26	Farnesylthiosalicylic acid	T103	UMLS:C0297002
28471040	35	89	lipid-polyethylene glycol-polymer hybrid nanoparticles	T103	UMLS:C1254351
28471040	94	103	treatment	T058	UMLS:C0087111
28471040	107	119	glioblastoma	T038	UMLS:C0017636
28471040	140	200	lipid-polyethylene glycol (PEG)-polymer hybrid nanoparticles	T103	UMLS:C1254351
28471040	230	243	tumour tissue	T017	UMLS:C0475358
28471040	249	266	active ingredient	T103	UMLS:C1372955
28471040	285	304	antineoplastic drug	T103	UMLS:C0003392
28471040	306	332	farnesylthiosalicylic acid	T103	UMLS:C0297002
28471040	334	337	FTA	T103	UMLS:C0297002
28471040	343	352	treatment	T058	UMLS:C0087111
28471040	356	368	glioblastoma	T038	UMLS:C0017636
28471040	370	396	Farnesylthiosalicylic acid	T103	UMLS:C0297002
28471040	405	518	poly(lactic-co-glycolic acid)-1,2 distearoyl-glycerol-3-phospho-ethanolamine-N [methoxy (PEG)-2000] ammonium salt	T103	UMLS:C1254351
28471040	520	533	PLGA-DSPE-PEG	T103	UMLS:C1254351
28471040	551	620	1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) hybrid nanoparticles	T103	UMLS:C1254351
28471040	630	638	prepared	T033	UMLS:C4082130
28471040	643	652	evaluated	T058	UMLS:C0220825
28471040	684	696	Cytotoxicity	T038	UMLS:C0596402
28471040	700	724	FTA-loaded nanoparticles	T103	UMLS:C0297002
28471040	752	776	rat glioma-2 (RG2) cells	T017	UMLS:C0007634
28471040	786	795	evaluated	T058	UMLS:C0220825
28471040	830	859	non-malignant cell line, L929	T017	UMLS:C0007600
28471040	874	910	Scanning electron microscopy studies	T058	UMLS:C0523160
28471040	953	967	smooth surface	T201	UMLS:C1182795
28471040	972	990	spherical in shape	T082	UMLS:C0332501
28471040	992	995	FTA	T103	UMLS:C0297002
28471040	1000	1024	FTA-loaded nanoparticles	T103	UMLS:C0297002
28471040	1030	1048	cytotoxic activity	T038	UMLS:C0596402
28471040	1057	1078	RG2 glioma cell lines	T017	UMLS:C0007600
28471040	1145	1150	DOTAP	T103	UMLS:C1254351
28471040	1152	1178	Magnetic resonance imaging	T058	UMLS:C0024485
28471040	1183	1198	histopathologic	T091	UMLS:C0677043
28471040	1199	1209	evaluation	T058	UMLS:C0220825
28471040	1213	1229	RG2 tumour cells	T017	UMLS:C0431085
28471040	1233	1249	rat glioma model	T038	UMLS:C0012644
28471040	1261	1272	Wistar rats	T204	UMLS:C0034716
28471040	1342	1346	drug	T103	UMLS:C1254351
28471040	1371	1395	FTA-loaded nanoparticles	T103	UMLS:C0297002
28471040	1404	1415	tumour size	T082	UMLS:C0475440
28471040	1528	1554	Farnesylthiosalicylic acid	T103	UMLS:C0297002
28471040	1563	1603	PLGA-DSPE-PEG-DOTAP hybrid nanoparticles	T103	UMLS:C1254351
28471040	1639	1651	glioblastoma	T038	UMLS:C0017636